Showing results (211-220 of 228) with videos related to

Sort By:
Pageof 23
ERJ Open Research|July 29, 2021
Training general practitioners in the ABC versus 5As method of delivering stop-smoking advice: a pragmatic, two-arm cluster randomised controlled trialSabrina Kastaun, Verena Leve, Jaqueline Hildebrandt, et al.
BMC Family Practice|July 29, 2019
Effectiveness of training general practitioners to improve the implementation of brief stop-smoking advice in German primary care: study protocol of a pragmatic, 2-arm cluster randomised controlled trial (the ABCII trial)Sabrina Kastaun, Verena Leve, Jaqueline Hildebrandt, et al.
Heart (British Cardiac Society)|June 7, 2012
Effect of smoke-free legislation on the incidence of sudden circulatory arrest in the NetherlandsDianne de Korte-de Boer, Daniel Kotz, Wolfgang Viechtbauer, et al.
BMC Public Health|December 11, 2012
The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trialPhilippe H J Hoogsteder, Daniel Kotz, Paul I van Spiegel, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 5, 2017
Construct and Predictive Validity of Three Measures of Intention to Quit Smoking: Findings From the International Tobacco Control (ITC) Netherlands SurveyKarin Hummel, Math J J M Candel, Gera E Nagelhout, et al.
Annals of Family Medicine|March 13, 2019
Antibiotic Prescribing for Acute Respiratory Tract Infections 12 Months After Communication and CRP Training: A Randomized TrialPaul Little, Beth Stuart, Nick Francis, et al.
Lancet (London, England)|August 7, 2013
Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trialPaul Little, Beth Stuart, Nick Francis, et al.
European Addiction Research|June 27, 2022
S3 Guideline "Smoking and Tobacco Dependence: Screening, Diagnosis, and Treatment" - Short VersionAnil Batra, Falk Kiefer, Stefan Andreas, et al.
Addiction (Abingdon, England)|April 21, 2018
The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trialOmara Dogar, Deepa Barua, Melanie Boeckmann, et al.
The Lancet. Global Health|October 18, 2020
Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trialOmara Dogar, Ada Keding, Rhian Gabe, et al.
Pageof 23